NASDAQ:AMIX Autonomix Medical Q2 2025 Earnings Report $2.99 +0.07 (+2.40%) As of 09:46 AM Eastern ProfileEarnings HistoryForecast Autonomix Medical EPS ResultsActual EPS-$51.87Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAutonomix Medical Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAutonomix Medical Announcement DetailsQuarterQ2 2025Date11/8/2024TimeAfter Market ClosesConference Call DateFriday, November 8, 2024Conference Call Time7:00AM ETUpcoming EarningsAutonomix Medical's Q1 2027 earnings is estimated for Wednesday, August 12, 2026, based on past reporting schedules, with a conference call scheduled on Friday, August 14, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Autonomix Medical Earnings HeadlinesAutonomix Medical Reports Preclinical Study Shows Neural Sensing Platform Can Detect and Localize Renal Nerve ActivityJuly 24 at 9:10 AM | quiverquant.comQAutonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical StudyJuly 24 at 9:00 AM | globenewswire.comTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.July 27 at 1:00 AM | Altimetry (Ad)Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation PlatformJuly 23, 2026 | globenewswire.comAutonomix Medical (NASDAQ:AMIX) Stock Price Up 1.4% - Here's WhyJuly 22, 2026 | americanbankingnews.comAutonomix Medical Receives U.S. Patent Expanding Neural Sensing Platform into Overactive Bladder Urology MarketJuly 15, 2026 | quiverquant.comQSee More Autonomix Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Autonomix Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Autonomix Medical and other key companies, straight to your email. Email Address About Autonomix MedicalAutonomix Medical (NASDAQ:AMIX), a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.View Autonomix Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 07/20- 07/24Telecom Earnings Reveal a Sector That Finally Looks HealthierAMD and Cerbras Create A New Blueprint For HardwareThis Tiny AI Supplier Could Be More Important Than the ChipmakersIntel Earnings Reveal Whether the Chip Selloff Created a BuyRTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?Meta Earnings Put AI Spending and Ad Growth Back in Focus Upcoming Earnings PACCAR (7/28/2026)Ford Motor (7/28/2026)Boeing (7/28/2026)Ecolab (7/28/2026)Rio Tinto (7/28/2026)Sherwin-Williams (7/28/2026)Visa (7/28/2026)Waste Management (7/28/2026)Corning (7/28/2026)KLA (7/28/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
